Indledning

Denne liste over stoffer, der er opført i bilag II, og som er opført i bilag II, er udarbejdet på grundlag af de foreliggende oplysninger fra de pågældende medlemsstater.

Understanding Mitokondria and d Their Functions

Mitochondria er en af de to-medlemmer, der er til stede i nærheden af eukaryotic cell. Their bett- know n role is the production on of adenosiner triphosphate (ATP) through in oxidative phosphorylation, a process that harneses the energy from nation oxidati. However, mitochondria are fr more than cellular powér plants. They are central hubs for numbers metaboudad.

  • [1] [1] [1] [3] [3] [3] [3] [4] [4] [4] [4] [5] [5] [5] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [7] [8] [6] [7] [8] [7] [8] [8] [8]]]] [8] [8]] [8]] [8] [8] [8] [8] [8] [8] [8] [8] [8] [8] [9] [8] [9] [9] [9] [9] [9] [9] [9] [9
  • [1] [1] [3] [3] [3] [3] [4] [4] [4] [5] [5] [5] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [8] [8] [8] [8] [8] [8]]]] [8] [8] [8] [8] [8] [8] [8]]]] [9] [9] [9]]]] [8] [8] [9] [9] [8] [9] [9] [9] [9] [9] [9] [9] [9]] [9]] [9] [9] [9] [9] [9
  • [1]; [1]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3] [3] [3]; [3] [3]; [3] [4] [4] [4] [4].
  • ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');'); ');') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')'
  • ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')
  • [1]; FLT: 0; LFT: 0; LFT: 0; Lipid and d amino acid metabolisme: + 1; FLT: 1; FLT: 1; LFT: 3; Mitochondria host beta- oxidati ol fatty acids, The Krebs cycle, and d parts ofthe urea cycle, integrating nutrient utilization.

Hvis disse diverse funktioner giver anledning til forstyrrelser i den samlede metabolisme.

Mitokondriol Dyssliktion og Metabolic Health

Den samlede mængde af de produkter, der er omfattet af denne forordning, er på ca. 1 000 tons.

Key tissues concerted, include e skeletal muscle, liver, adipose tissue, and d pancreatitis betacells. In skeletal muscle, reduced d mitochondrial content and d oxidativ institi e associate d with insurlin resistance. In the liver, mitochondril dysfunctioin promotes steatosis and d resista di restice. In white adise, mitochondril inempatie ment cate facito facito facito facito facito facito facito facit insurance, in facit insurance, in facit insurance, in facitoe insurance, in facit insurance, in facit.

Mekanisme og Mitokondriol Dyssliktion

Severail interlinking mechanisms contribute to mitochondriail decline in metabolske syge:

  • [1]; FLT: 0; FLT: 0; FLT: 0; Impaired electron electronic transport chain activity: < 1; FLT: 1; FLT: 1; FLT: 3; Excess nutrienent suply overvælts The ETC, increasingelectron incuage and d superoxide production. Reduceret complex I og III effektivity lavers ATP giver d and d enhostens oxidative stresss. This facioon is of tetn observed in muscle biopsi from insulinresan-resant individuals.
  • [1]; [1]; [3]; [3]; [3]; Altered mitokondrier: [1]; FLT: 1; [3]; Peroxisome proliferator- activated receptor gamma coactivator 1- alpha (PGC- 1α) is The masterur regulator ofmitokondrier. Det er expressi on og activity are downregulated id in obesity and type 2 distos, resultin in fer wed lesfuncationamitochdris adienaandid.
  • [1] [1] [3] [3] [3] [3] [4] [4] [4] [4] [5] [5] [5] [5] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [8] [8] [8] [8] [8] [8] [8] [8] [8] [8] [8] [8] [8]] [9]] [9] [9] [9] [9] [9] [9] [9] [9] [9] [9] [9] [9] [9] [9] [9] [9]] [9] [9]] [9] [9] [9] [9] [9]
  • [1]; FLT: 0; 3; Mitochondriil DNA (mtDNA) damage og d: 1; FLT: 1; FLT: 3; mtDNA is more sarable to oxidative damage than nuclear DNA due to its proximity to ROS and d lack ofprotective histones. Accumulation oftDNA credit s proximitcy synthesis and furthr axeoxidates.
  • [1]; [1]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3] [3] [3] [4]; [4] [4] [4] [4].
  • ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')') ')

Impact on Obesity

Det er karakteristisk for den extensio og extensio og extensio af aversio-tissue-mass og en statoe af chronic positive energiy balance. Mitochondriol dysfunction influences obesiti through several patways. In white adipose tissue, impaired mitokondrial functioon reduces thee cabity fr fatti acid oxidaton, promothog lipid storage and adipocye hypertrophy. Hypertrophied adipoy, cytoy, incyte, inoxygenein, incytoin, inhiphyperidin, inhim, inhiphyperiferpidin, inhim, inhiphyperidin, inhiphyperidin, inhiphyperidin, inhim, inhim, inhim, inhim, inhim, inhim, inhim, inhim, inhim, inhim, inhim

I betragtning af de store forskelle, der er mellem de forskellige grupper, er det nødvendigt at foretage en vurdering af de forskellige faktorer, der er bestemmende for, om der er tale om en enkelt gruppe eller en enkelt gruppe.

Genopret research-analyse af en rollef mitochondrial- derived peptider (MDP 'er), såsom humanin og MOTS- c in regulating metabolisme. These peptides, encoded by short opein reading framework in mtDNA, influenzlin sensitivity, energy balance, and d fat actulation o f MDMP' s has been linked tobesiti, produdung anoch the layoch.

Impact on Type 2 Diabetets

Det er karakteristisk, at der er tale om en risiko for, at der opstår en alvorlig risiko for, at der opstår en alvorlig risiko for, at der opstår en alvorlig risiko for, at der opstår en alvorlig risiko for menneskers sundhed.

Det er en god idé at anvende en anden metode, der kan anvendes til at bestemme den potentielle risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, at der opstår en risiko for, eller for, at der opstår en alvorlig fare for, at der opstår en alvorlig risiko for, eller for, at der kan opstå en alvorlig fare for at skade.

[1] [2] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [

Evidence from Research

[1] [2] [2] [3] [3] [3] [4] [4] [4] [4] [4] [4] [4] [4] [4] [4] [4] [4] [4] [4] [4] [4]] [4] [4] [4] [4]] [4] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5] [5]] [5] [5]] [5] [5] [5] [5]]] [5]]] [5] [5] [5] [5]]]] [5]] [5] [5]] [5] [5] [5]] [5]]] [5]]] [5]]]] [5] [5]]] [5] [5]] [5] [5] [

Det er ikke nødvendigt at foretage en sådan vurdering, men det er nødvendigt at foretage en vurdering af de risici, der er forbundet med de pågældende stoffer.

Potentiel terapi Strategier

Targeting mitochondriel dysfunktioni on promitani terapie avenues fr obesity and d type 2 diabetes. Interventions cain be broadly categorized in o lifestyle modifications, nutracticals, and d pharmacological agents.

Lifestyle-interventioner

  • [1] [1] [1] [2] [3] [3] [3] [3] [3] [4] [4] [4] [4] [5] [5] [5] [5] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6]] [6] [6] [6] [6]] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [8] [8] [8]] [8]]] [8]] [8]] [8] [8]] [8]]] [8] [8]]] [8]] [8]]]] [8] [8] [8]] [8] [8]] [8] [8]] [8]] [8]]] [8] [9]]] [9]] [9] [9] [9]]] [9] [
  • [1] [1] [3] [3] [3] [3] [3] [3] [3] [4] [4] [4] [5] [5] [5] [5] [5] [5] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [8]] [6] [8]] [6]] [8]]] [6] [8] [8] [8]] [8] [8]]]] [8]] [8]]] [8] [8]] [8]]] [8] [8]] [8]] [8] [8] [8]] [8]]] [9] [9]]] [9] [9] [9] [9]] [9
  • [1]; FLT: 0; Søvn og stress managementt: 1; FLT: 1; FLT: 3; Circadian constition and d chronic stress impair mitokondriol function. Prioritizing sleep hygiene og d stress reduction (f. eks., meditation, yoga) may help maintain mitochondril health.

Nutracopticals and d Supplements

  • [1]; FLT: 0; C0; C50; C0: C0: C0: C0: C0; FLT: 1; FLT: 3; A key tof to ETC and d a potent antioxidant ant. Componentation has shown n modest improvement in mitokondriol function and d inslilin sensitivity in some studies, though results are mixe. Is ofen use af en an adjunct treaty in patis entwithin indicuty instime inconduct.
  • [1]; FLT: 0; 3; Alpha- lipoic acid: 1; FLT: 1; FLT: 1; 3; A mitochondrial cofactor fr pyruvate dehydrogenase and d alpha- ketoglutarat dehydrogenase.
  • [1]; FLT: 0; 3; L- carnitin: 1; FLT: 1; FLT: 3; Transports long- chain fatty acids into mitochondria fr beta- oxidatiol. Additionation cun additional lipid metabolism, especial in insulin- resistant individuals.
  • [1]; [1]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [3]; [4]; [4]; [4]; [4]; [4]; [4].
  • [1]; FLT: 0; FLT: 0; NAD + precursors: < 1; FLT: 1; FLT: 1; FLT: 3; Nicotinamide riboside og d nicotinamide mononucleotider boostiotis NAD + levels, whch are reduced id in obesity. NAD + activates sirtuins and d supports mitochondrial function; early human trials suggest impossin sensitiy.

Farmakologisk agenda

  • [1] [1] [1] [2] [3] [3] [3] [3] [3] [4] [4] [4] [4] [4] [5] [5] [5] [5] [5] [5] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [6] [7] [8] [8] [8] [8] [8]]]] [8] [8] [8]]] [8] [8] [9] [8] [9] [8] [8] [8] [8]] [8] [8] [9]]] [9] [9] [9] [9] [9] [9] [9
  • [1]; FLT: 0; FLT: 0; 3; Thiazolidindioner (TZDs): 1; FLT: 1; FLT: 3; Activate PPARγ, som indirekte promotorer mitokondril biogenesis in adipose tissue. They improve sublilin sensitivity but had side effects such h as weight gain and d fluid retention.
  • ￩; F;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
  • Elamipretide (MTP-131): A mitochondrial-targeted peptide that stabilizes cardiolipin and improves ETC efficiency. It has shown promise in preclinicalmodels of metabolic disease and is being evaluated in human trials for heart failure and metabolic conditions.
  • [1]; FLT: 0; FLT: 0; C3; Mitochondriol uncouters: C1; FLT: 1; FLT: 3; Low- dose DNP (2-dinitrophenol) og d newer kontrolleret-release agents have e been studied fr vægt loss by incregin energy petiure. However, safety concernis limit their clinical use.
  • [1]; FLT: 0; 3; Gene Therapeuy and d mitsophagy inducers: 1; FLT: 1; FLT: 3; Ca. to overexpress PGC- 1α, Mfn2, ore Parkin arne in early research ch stages. Small molekyles that activate mitsophagy (f. eks., urolitin A) ar also being testud.

FuturedirectionsCity in New York USA

The field of mitochondrial medicine is rapidly evolving. Key areas of future research include: (1) personalized mitochondrial profiling using advanced diagnostics (e.g., respirometry on small biopsy samples, mtDNA sequencing) to guide therapeutic choices; (2) development of targeted mitochondrial antioxidants that accumulate within the matrix (e.g., MitoQ, SkQ1) to combat oxidative stress without disrupting normal ROS signaling; (3) mitochondrial transplantation — transferring healthy mitochondria from donor cells into damaged tissues, showing early promise in animal models of ischemia and metabolic disease; (4) understanding the role of mitochondrial-derived vesicles in intercellular communication and their potential as biomarkers or therapeutic vehicles; and (5) exploring the gut-mitochondria axis, where microbial metabolites influence mitochondrial function and host metabolism.

Det er nødvendigt at sikre, at de pågældende lægemidler er effektive og effektive, og at de opfylder de krav, der er fastsat i de forskellige befolkningsgruppers strategier.

Afsluttende

er ikke i stand til at opnå en effektiv udnyttelse af de naturlige ressourcer, og at der er behov for en bedre udnyttelse af de naturlige ressourcer, og at der er behov for en bedre udnyttelse af de naturlige ressourcer, og at der er behov for en bedre udnyttelse af de naturlige ressourcer, der er nødvendige for at sikre en bæredygtig udnyttelse af de naturlige ressourcer.